Discontinuation of immunosuppression in patients with immune‐mediated drug‐induced liver injury or idiopathic autoimmune hepatitis: A case–control study
Abstract Background and Aim Drug‐induced liver injury (DILI) may present with autoimmune features and require immunosuppressive therapy (IST) to reach biochemical response. Discontinuation of IST without hepatitis relapse may be more frequent in these patients as compared to patients with classical...
Main Authors: | Jeremy Hassoun, Nicolas Goossens, Sophie Restellini, Lucas Ramer, Marie Ongaro, Emiliano Giostra, Antoine Hadengue, Laura Rubbia‐Brandt, Laurent Spahr |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | JGH Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/jgh3.12862 |
Similar Items
-
Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage
by: Sufang Wei, et al.
Published: (2024-03-01) -
A clinical case of diagnosis of autoimmune hepatitis at the stage of liver cirrhosis
by: O. A. Svitlytska, et al.
Published: (2023-07-01) -
Impact of SARS-CoV-2 infection on liver disease
by: Salgüero Fernández Sergio, et al.
Published: (2022-06-01) -
Liver Dysfunction in Hypothyroid Non-Pregnant Women
by: Mohammad Yousaf, et al.
Published: (2018-03-01) -
Autoimmune Hepatitis in Children: The Current State of the Problem
by: G. V. Volynets, et al.
Published: (2018-11-01)